CCPA Imposes ₹8 Lakh Fine on Firm for Violating Consumer Law with Unsubstantiated Infant Development Claims

CCPA Fines E-Commerce Platform Rs 5 Lakh for Sale of Sub-Standard Toys Violating BIS QCO

The CCPA has penalized an e-commerce platform Rs 5 lakh for allowing the sale of toys that failed BIS quality standards under the Toys Quality Control Order (QCO) 2020. The regulator held the platform liable for its active role in the sale process, rejecting its defense as a mere intermediary, reinforcing strict consumer protection accountability for e-commerce entities.

FSSAI Issues Prohibition Order to Dabur for Misleading '100%' Claims on Food Products

FSSAI's crackdown on misleading '100%' claims on food products is a major regulatory action that tests your understanding of the FSS Act, 2006, and the FSS (Advertising & Claims) Regulations, 2018. This news is relevant for Prelims (FSSAI, regulations, consumer protection) and Mains (food safety, ethics in business, regulatory framework).

FSSAI Tightens Rules on Food Claims: ‘100% Pure’ and Health Labels Under Scrutiny

FSSAI is proposing stricter regulations on food product claims like '100% Pure' and health endorsements, following concerns over misleading marketing—especially for products like Bournvita marketed for children's nutrition. This move aims to protect consumers and enforce honest labeling.

FSDA Cancels 16 Pharma Licences, Suspends Pfizer Depot in Bengaluru Fake Drug Bust Worth ₹5 Cr

Karnataka FSDA has cancelled 16 pharma licences and suspended 8 others, including Pfizer's depot, after seizing counterfeit drugs worth ₹5 crore from farmhouses. The racket involved refilling cheap drugs into vials of expensive MNC brands, posing a serious public health risk. This highlights gaps in drug regulatory enforcement and the need for stricter supply chain vigilance.

MahaRERA Strikes Down Builder's Unilateral Cancellation Clause, Orders Interest from Oct 2023 Under RERA Act

MahaRERA has declared illegal a contractual clause that allowed a builder to unilaterally cancel a flat allotment via Power of Attorney, reinforcing statutory safeguards under the RERA Act. The developer was ordered to pay interest for delayed possession from October 1, 2023. This ruling is a key example of regulatory protection for homebuyers and a must-know for exams covering RERA, consumer rights, and state-level governance.

Maharashtra FDA Permanently Cancels License of Pune Pharma Firm Over GMP Violations & 6 NSQ Medicines

The Maharashtra FDA has permanently cancelled the Ayurvedic medicine manufacturing license of InduCare Pharma Pvt. Ltd. after finding six medicines contaminated with fungi, insects, and larvae, alongside severe GMP violations. This action highlights the regulatory crackdown under the Drugs and Cosmetics Act, 1940, a key area for health governance and prelims questions on drug quality standards.

MCA Data Reveals Only 9 Women CEOs, 25 MDs in India's Top 500 Listed Companies

Ministry of Corporate Affairs data tabled in Lok Sabha reveals severe underrepresentation of women in top corporate leadership: only 9 CEOs and 25 MDs among India's 500 largest listed companies. This directly impacts the UPSC/state PSC themes of women empowerment, corporate governance, and the effectiveness of legal mandates under the Companies Act, 2013.

VB-G RAM G Scheme: Karnataka Person-Days Fall 70% in July, 805 GPs with Nil Expenditure

The new VB-G RAM G scheme, which replaced MGNREGA from July 1, 2026, has seen a drastic drop in employment generation in Karnataka - only 17.98 lakh person-days in July 2026 vs 61.48 lakh in July 2025 under MGNREGA. Implementation delays, lack of clarity, and procedural hurdles are blamed. This is critical for understanding rural employment policy shifts.